Marios Dimitriou

1.4k citations

17 papers · 465 indexed · h-index 13

Co-authors: Dimitris L. Kontoyiannis Eva Hellström‐Lindberg Anthie Yiakouvaki Christina Eftychi Stamatis Theocharis Ioannis Karakasiliοtis Monika Jansson Teresa Mortera‐Blanco
Topics: Acute Myeloid Leukemia Research (10 papers)RNA modifications and cancer (4 papers)Histone Deacetylase Inhibitors Research (3 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Journal of Clinical Investigation Nature Communications Blood
Partner nations: Sweden United Kingdom United States

In The Last Decade

Marios Dimitriou

17 papers receiving 461 citations

Peers

Countries citing papers authored by Marios Dimitriou

Since Specialization

Citations

This map shows the geographic impact of Marios Dimitriou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios Dimitriou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios Dimitriou more than expected).

Fields of papers citing papers by Marios Dimitriou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marios Dimitriou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios Dimitriou. The network helps show where Marios Dimitriou may publish in the future.

Co-authorship network of co-authors of Marios Dimitriou

This figure shows the co-authorship network connecting the top 25 collaborators of Marios Dimitriou. A scholar is included among the top collaborators of Marios Dimitriou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marios Dimitriou. Marios Dimitriou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation 2023 ·Nature Communications ·Anders Mälarstig,Felix Graßmann,(unknown),Marios Dimitriou,(unknown),Marike Gabrielson,Karl Smith‐Byrne,Cecilia Engel Thomas,Tzu-Hsuan Huang,Simon K. G. Forsberg,Per Eriksson,(unknown),Mattias Johansson,(unknown),Helgi B. Schiöth,Per Hall,Jochen M. Schwenk,Kamila Czene,Åsa K. Hedman	19
2	Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation 2023 ·Blood ·Marios Dimitriou,Teresa Mortera‐Blanco,Magnus Tobiasson,(unknown),(unknown),Kari Högstrand,Mohsen Karimi,Gunilla Walldin,Monika Jansson,(unknown),Per Ljungman,Saskia Langemeijer,Tetsuichi Yoshizato,Eva Hellström‐Lindberg,Petter Woll,Sten Eirik W. Jacobsen	5
3	m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis 2023 ·Molecular Cell ·Maciej Cieśla,Phuong Cao Thi Ngoc,Sowndarya Muthukumar,Gabriele Todisco,(unknown),H Fritz,Marios Dimitriou,Danny Incarnato,Eva Hellström‐Lindberg,Cristian Bellodi	21
4	Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome 2022 ·Nature Cell Biology ·Nicola Guzzi,Sowndarya Muthukumar,Maciej Cieśla,Gabriele Todisco,Phuong Cao Thi Ngoc,(unknown),Roberto Munita,Serena Fazio,Simon Ekström,Teresa Mortera‐Blanco,Monika Jansson,Yasuhito Nannya,Mario Cazzola,Seishi Ogawa,Luca Malcovati,Eva Hellström‐Lindberg,Marios Dimitriou,Cristian Bellodi	78
5	The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS 2022 ·Blood Advances ·(unknown),Teresa Mortera‐Blanco,Pedro Luís Moura,(unknown),(unknown),(unknown),Gunilla Walldin,Magnus Tobiasson,Birgitta Sander,Marios Dimitriou,Sten Eirik W. Jacobsen,Petter Woll,Martin Jädersten,Eva Hellström‐Lindberg	2
6	Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells 2020 ·PLoS Pathogens ·Birgitta Lindqvist,Sara Svensson Akusjärvi,Anders Sönnerborg,Marios Dimitriou,J. Peter Svensson	21
7	A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes 2019 ·Leukemia ·(unknown),Teresa Mortera‐Blanco,Marios Dimitriou,Thibault Bouderlique,Monika Jansson,(unknown),Simona Conte,Mohsen Karimi,Birgitta Sander,Iyadh Douagi,Petter Woll,Eva Hellström‐Lindberg	16
8	Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm 2018 ·Blood Advances ·(unknown),Monika B. Dolinska,Lakshmi Sandhow,Makoto Kondō,Anne‐Sofie Johansson,Thibault Bouderlique,Ying Zhao,Xidan Li,Marios Dimitriou,George Z. Rassidakis,Eva Hellström‐Lindberg,Nagahiro Minato,Julian Walfridsson,David T. Scadden,Mikael Sigvardsson,Hong Qian	28
9	SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells 2017 ·Blood ·Teresa Mortera‐Blanco,Marios Dimitriou,Petter Woll,Mohsen Karimi,(unknown),Simona Conte,Magnus Tobiasson,Monika Jansson,Iyadh Douagi,Matahi Moarii,Leonie Saft,Elli Papaemmanuil,Sten Eirik W. Jacobsen,Eva Hellström‐Lindberg	47
10	Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations 2016 ·Haematologica ·Christian Scharenberg,Valentina Giai,Andrea Pellagatti,Leonie Saft,Marios Dimitriou,Monika Jansson,Martin Jädersten,Alf Grandien,Iyadh Douagi,Donna Neuberg,Katarina LeBlanc,Jacqueline Boultwood,Mohsen Karimi,Sten Eirik W. Jacobsen,Petter Woll,Eva Hellström‐Lindberg	29
11	Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality 2016 ·Oncotarget ·Marios Dimitriou,Petter Woll,Teresa Mortera‐Blanco,Mohsen Karimi,David C. Wedge,Helen Doolittle,Iyadh Douagi,Elli Papaemmanuil,Sten Eirik W. Jacobsen,Eva Hellström‐Lindberg	16
12	Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia 2016 ·Blood ·Yaser Heshmati,(unknown),(unknown),Sten Linnarsson,Marios Dimitriou,Indranil Sinha,Sören Lehmann,Hong Qian,Julian Walfridsson	4
13	Mutations in histone modulators are associated with prolonged survival during azacitidine therapy 2016 ·Oncotarget ·Magnus Tobiasson,Donal P. McLornan,Mohsen Karimi,Marios Dimitriou,Monika Jansson,(unknown),Martin Jädersten,Greger Lindberg,(unknown),Austin Kulasekararaj,Johanna Ungerstedt,Andreas Lennartsson,Karl Ekwall,Ghulam J. Mufti,Eva Hellström‐Lindberg	29
14	Mutations in Histone Modulators Are Associated with Prolonged Survival during Azacitidine Therapy 2015 ·Blood ·Magnus Tobiasson,Donal P. McLornan,Mohsen Karimi,Marios Dimitriou,Monika Jansson,(unknown),Martin Jädersten,Greger Lindberg,(unknown),Austin Kulasekararaj,Johanna Ungerstedt,Andreas Lennartsson,Karl Ekwall,Ghulam J. Mufti,Eva Hellström‐Lindberg	1
15	Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation inSF3B1mutated refractory anaemia with ring sideroblasts 2015 ·British Journal of Haematology ·Simona Conte,Shintaro Katayama,Liselotte Vesterlund,Mohsen Karimi,Marios Dimitriou,Monika Jansson,Teresa Mortera‐Blanco,Per Unneberg,Elli Papaemmanuil,Birgitta Sander,Tiina Skoog,Peter J. Campbell,Julian Walfridsson,Juha Kere,Eva Hellström‐Lindberg	30
16	Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis 2011 ·Journal of Clinical Investigation ·Anthie Yiakouvaki,Marios Dimitriou,Ioannis Karakasiliοtis,Christina Eftychi,Stamatis Theocharis,Dimitris L. Kontoyiannis	107
17	Post-transcriptional Regulators in Inflammation: Exploring New Avenues in Biological Therapeutics 2007 ·PubMed ·(unknown),Marios Dimitriou,Dimitris L. Kontoyiannis	12

About Marios Dimitriou

Marios Dimitriou is a scholar working on Hematology, Genetics and Virology, having authored 17 papers that have together received 465 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), RNA modifications and cancer (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Hematology (165 citations), Genetics (70 citations) and Cancer Research (98 citations). Marios Dimitriou has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Dimitris L. Kontoyiannis, Eva Hellström‐Lindberg, Anthie Yiakouvaki, Christina Eftychi, Stamatis Theocharis, Ioannis Karakasiliοtis, Monika Jansson, Teresa Mortera‐Blanco, Mohsen Karimi and Petter Woll. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact